DanCann Pharma A/S: CEO Jeppe Krog Rasmussen upgrades his shareholding in DanCann Pharma A/S, and now holds more than 26% of the Company
COPENHAGEN, Denmark, 22 March 2021 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) hereby announce that Jeppe Krog Rasmussen, Founder, Board Member and CEO at DanCann Pharma A/S has privately through his holding company (JKR INVESTMENT GROUP ApS) bought 50,000 shares in DanCann Pharma A/S at an average price of DKK 3.25 per share.The shares were purchased in the ongoing trading on Spotlight Stock Market on Friday 19 March 2021. Following this transaction, Jeppe Krog Rasmussen now directly through his holding company (JKR INVESTMENT GROUP ApS) controls 5,430,000